JNDOF yields 3.09% · MRK yields 2.76%● Live data
📍 JNDOF pulled ahead of the other in Year 1
Combined, JNDOF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JNDOF + MRK for your $10,000?
JINS HOLDINGS Inc., through its subsidiaries, engages in the planning, manufacturing, sales, and import/export of eyewear and fashion accessories in Japan. It offers airframes; computer glasses under the JINS SCREEN name; JINS Switch, an eyewear that uses magnet to attach sunglasses to frame; children's glasses; JINS VIOLET lenses for selectively block harmful light; JINS MEME, an eyewear, which enables visualization of one's physical and mental state; and contact lenses under the JINS 1DAY name through stores under the JINS Shibuya, JINS Harajuku, and rim of jins LUMINE Shinjuku names, as well through online and other channels. The company is also involved in the operation of shared workspaces; developing and selling work environment products; provision of workspace consulting; and contracting business for agriculture work. In addition, it operates bakery cafes. The company was formerly known as JINS Inc. and changed its name to JINS HOLDINGS Inc. in July 2019. JINS HOLDINGS Inc. was incorporated in 1988 and is headquartered in Tokyo, Japan.
Full JNDOF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.